Document:

Registration Rights Agreement

 Exhibit 4.4 
  
 REGISTRATION RIGHTS AGREEMENT 
  

This REGISTRATION RIGHTS AGREEMENT, dated May 26, 2005 (this “Agreement”) is entered by and between Credence Systems
Corporation, a Delaware corporation (the “Company”) and each of undersigned investors (each individually, an “Investor” and, collectively, the “Investors”). 
  
 RECITALS 
  
 WHEREAS, concurrently with the execution of this Agreement, the Company, each of the Investors, Schlumberger
Technology Corporation, NPTest Holding Corporation and NPTest Acquisition Corporation are entering into a Settlement Agreement (the “Settlement Agreement”) pursuant to which the Company has agreed to issue to the Investors shares
(the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”); and 
  
 WHEREAS, the Settlement Agreement also requires the Company and the Investors to execute this Agreement to provide for certain registration rights
for the benefit of the Investors. 
  
 NOW, THEREFORE, in
consideration of the foregoing recitals and the mutual promises hereinafter set forth, the parties hereto agree as follows: 
  
 1. DEFINITIONS. As used in this Agreement the following terms shall have the following respective meanings. Capitalized terms used in this
Agreement not otherwise defined shall have the meanings ascribed to them in the Settlement Agreement. 
  
 1.1 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
  
 1.2 “Form S-3” means such form under the Securities Act as in effect on the date hereof or any successor
registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 
  
 1.3 “Holder” means any Investor or permitted assignee
pursuant to Section 2.6 hereof owning of record Registrable Securities that have not been sold to the public. 
  
 1.4 “Register,” “registered,” and “registration” refer to a registration effected by preparing and
filing a Registration Statement in compliance with the Securities Act and pursuant to Rule 415 promulgated under the Securities Act, and the declaration or ordering of effectiveness of such Registration Statement or document. 
  
 1.5 “Registrable Securities” means (i) Common Stock issued
pursuant to the Settlement Agreement; and (ii) any Common Stock issued as a dividend or other distribution with respect to, or in exchange for or in replacement of, this Common Stock. Notwithstanding 

 
the foregoing, Registrable Securities shall not include any securities sold by a person to the public either pursuant to a Registration Statement or Rule 144
or sold in a private transaction in which the transferor’s rights under Section 2 of this Agreement are not assigned. 
  
 1.6 “Registration Expenses” means all expenses incurred by the Company in complying with Sections 2.1 and 2.3 hereof, including, without
limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, reasonable fees and disbursements of one counsel for the Investors not to exceed $10,000, blue sky fees and expenses, and the expense
of any special audits incident to or required by any such registration (but excluding discounts and commissions relating to a sale). 
  
 1.7 “Registration Statement” means a shelf registration statement on Form S-3 pursuant to Rule 415 promulgated under the
Securities Act covering the resale of the Registrable Securities. 
  
 1.8 “Rule 144” means Rule 144 or any other similar or analogous rule promulgated under the Securities Act. 
  
 1.9 “Securities Act” means the Securities Act of 1933, as amended. 
  
 1.10 “SEC” or “Commission” means the Securities and Exchange Commission. 
  
 2. REGISTRATION. 
  
 2.1 Shelf Registration. 
  
 (a) Mandatory Registration. Subject to the conditions of this
Section 2.1, as soon as reasonably practicable, but in no event later than June 13, 2005 the “Filing Deadline”), the Company shall prepare and file the Registration Statement with respect to all Registrable Securities and use its
reasonable best efforts to cause such Registration Statement to be declared effective under the Securities Act, as soon as practicable (but in no event later than 60 days after the filing of the Registration Statement). The Company shall use its
reasonable best efforts to keep the Registration Statement continuously effective until the earliest of (i) the date that all of the Registrable Securities have been sold, (ii) 360 days after the time the Registration Statement is first declared
effective by the SEC (plus the aggregate number of days during which sales are suspended or the registration statement is not otherwise effective following the initial effective date), (iii) the date that all Registrable Securities covered by the
Registration Statement may be sold by the Holders without exceeding the volume restrictions imposed by Rule 144. 
  
 (b) Limitation on Registration. Notwithstanding anything to the contrary in this Agreement, the Company may suspend the sales of the Registrable
Securities as follows: 
  
 (i) During the first one hundred
eighty (180) days after the initial effective date of the Registration Statement, twice for not more than thirty (30) calendar days in the aggregate; and 
  

 2 

 (ii) During the next one hundred eighty (180) days, twice for not more than sixty (60) calendar days in
the aggregate; 
  
 if, in each such case, the Company shall furnish to the Holders
a certificate signed by the Chief Executive Officer of the Company stating that in his or her good faith judgment, the Company is engaged in a non-public activity or there is a pending material development the disclosure of which would be seriously
detrimental to the Company; provided, that the Company shall use all reasonable efforts to lift the suspension at the earliest practicable time; provided, further, that the Company shall not suspend sales hereby unless the Company concurrently
suspends sales under each and every other registration statement of the Company currently on file other than registration statements on Form S-8. Notwithstanding the foregoing, the Company shall use its reasonable best efforts to keep the
Registration Statement continuously effective during any period in which sales are suspended, and shall ensure that the prospectus has been amended or supplemented from time to time in compliance with applicable law and timely delivered to Holders,
except when sales have been suspended as permitted above. 
  
 (c) If the Company suspends sales pursuant to the preceding subsection, the Company will again deliver written notice to Holder when such suspension is no longer necessary, within the periods permitted hereby. Holder agrees that, as
a condition to the receipt of the registration rights contained herein, upon receipt of any written notice from the Company described in this Section 2.1(c) that suspends sales of Registrable Securities thereunder, Holder shall forthwith discontinue
disposition of Registrable Securities and cease to deliver or use the related prospectus until such Holder receives copies of a supplemented or amended prospectus from the Company, or until it is advised in writing by the Company that the use of the
prospectus may be resumed. The Company shall deliver to Holder any such supplement or amended prospectus electronically and within the suspension periods permitted above. 
  
 2.2 Registration Expenses. Except as specifically provided herein, the Company shall bear all Registration Expenses.

  
 2.3 Obligations Of The Company. The Company shall, as
soon as practicable: 
  
 (a) prepare and file with the
SEC such amendments and supplements to the Registration Statement and the prospectus used in connection with the Registration Statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all
Registrable Securities; 
  
 (b) prepare and file with the
SEC such amendments and supplements to such Registration Statement and the prospectus used in connection with such Registration Statement as may be necessary to add any permitted assignee or transferee of any Holder as a “selling
stockholder” therein, subject to receipt of the requisite information regarding such “selling stockholder”; 
  

 3 

 (c) furnish to the Holders such number of copies of a prospectus in conformity with the
requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 
  
 (d) use its best efforts to register and qualify the securities covered by such Registration Statement under such
other securities or Blue Sky laws of such limited jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to incur significant cost or qualify
to do business or to file a general consent to service of process in any such states or jurisdictions; 
  
 (e) furnish to each Holder upon request (i) a written statement by the Company that it has complied with the reporting requirements of the
Securities Act and the Exchange Act, or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3, (ii) a copy of the most recent annual or quarterly report of the Company and (iii) such other information as may be
reasonably requested in availing each Holder of any rule or regulation of the SEC which permits the selling of any Registrable Securities pursuant to Form S-3; 
  

(f) notify each Holder of Registrable Securities covered by such Registration Statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in the Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; 
  
 (g) cause all such Registrable Securities registered hereunder to be listed on the Nasdaq National Market; and 
  
 (h) include disclosure in the “plan of distribution”
section of the prospectus that permits the Holders to sell pursuant to open-market transactions, block trades, and such other means as the Holders reasonably request and to file such amendments or supplements as necessary to permit and effect the
same; provided, that the Company shall not disclose that the Holders are or may be deemed to be “underwriters” under the Securities Act or otherwise. 
  

2.4 Delay Of Registration; Furnishing Information. 
  
 (a) No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any
controversy that might arise with respect to the interpretation or implementation of this Section 2. 
  
 (b) It shall be a condition precedent to the obligations of the Company to take any action pursuant to Section 2.1 or Section 2.3 that the selling
Holders shall furnish to the Company such information regarding themselves, the Registrable Securities held by them and the intended method of disposition of such securities as shall be required to effect the registration of their Registrable
Securities. 
  

 4 

 2.5 Indemnification. In the event any Registrable Securities are included in a Registration
Statement pursuant to Section 2.1: 
  
 (a) To the extent
permitted by law, the Company will indemnify and hold harmless each Holder, the partners, officers, directors and legal counsel of each Holder, any underwriter (statutory or otherwise, as defined in the Securities Act) for such Holder and each
person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act,
the Exchange Act or other federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a
“Violation”) by the Company: (i) any untrue statement or alleged untrue statement of a material fact contained in, or incorporated by reference in, the Registration Statement, including any final prospectus contained therein or any
amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the
Company of the Securities Act, the Exchange Act, any state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law in connection with the offering covered by the Registration
Statement; and the Company will reimburse each such Holder, partner, officer or director, underwriter or controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss,
claim, damage, liability or action; provided, however, that the indemnity agreement contained in this Section 2.5(a) shall not apply (x) to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is
effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based
upon a Violation which occurs in reliance upon and in conformity with written information furnished for use in connection with such registration by such Holder, partner, officer, director, underwriter or controlling person of such Holder or (y) if
the Violation arises from the failure of the Holder, directly or indirectly, to deliver a prospectus to the purchaser when a prospectus was timely made available by the Company to the Holder. With respect to the preceding clause, the parties hereto
agree that the only written information from the Holder, partner, officer, director, underwriter or controlling person of such Holder shall be the names of the Holder and the number of Registrable Securities issued by the Company to such Holder, in
the absence of a written statement from such Holder to the Company that specifically states that such information is being furnished pursuant to this specific section. 
  
 (b) To the extent permitted by law, each Holder will, if Registrable Securities held by such Holder are included in
the securities as to which such registration qualifications or compliance is being effected, indemnify and hold harmless the Company, each of its directors, its officers, and legal counsel and each person, if any, who controls the Company within the
meaning of the Securities Act, any underwriter and any other Holder selling securities under such Registration Statement or any of such other Holder’s partners, directors or officers or any person who controls such Holder, against any losses,
claims, damages or liabilities (joint or several) to which the Company or any such director, officer, controlling person, underwriter or other such Holder, or partner, director, officer or controlling person of such other Holder may become subject
under the Securities Act, the Exchange Act or other federal or state law, insofar 

  

 5 

 
as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and
only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder for use in connection with such registration; and each such Holder will reimburse any legal or other expenses
reasonably incurred by the Company or any such director, officer, controlling person, underwriter or other Holder, or partner, officer, director or controlling person of such other Holder in connection with investigating or defending any such loss,
claim, damage, liability or action if it is judicially determined that there was such a Violation; provided, however, that the indemnity agreement contained in this Section 2.5(b) shall not apply to amounts paid in settlement of any such
loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; provided further, that in no event shall any indemnity under this Section 2.5 exceed
the proceeds from the offering received by such Holder. 
  
 (c) Promptly after receipt by an indemnified party under this Section 2.5 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made
against any indemnifying party under this Section 2.5, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so
desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own
counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between
such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if materially prejudicial to
its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 2.5, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability
that it may have to any indemnified party otherwise than under this Section 2.5. 
  
 (d) If the indemnification provided for in this Section 2.5 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any losses, claims, damages or liabilities
referred to herein, the indemnifying party, in lieu of indemnifying such indemnified party thereunder, shall to the extent permitted by applicable law contribute to the amount paid or payable by such indemnified party as a result of such loss,
claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the Violation(s) that resulted in such loss, claim,
damage or liability, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by a court of law by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission; provided that in no event shall any contribution by a Holder hereunder exceed the proceeds from the offering received by such Holder. 
  

 6 

 (e) The obligations of the Company and Holders under this Section 2.5 shall survive completion of
any offering of Registrable Securities in a Registration Statement and the termination of this Agreement. No indemnifying party, in the defense of any such claim or litigation, shall, except with the consent of each indemnified party, consent to
entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

  
 2.6 Assignment Of Registration Rights. The
rights to cause the Company to register Registrable Securities pursuant to this Section 2 may be assigned by a Holder only to a transferee or assignee of Registrable Securities which (i) is a current shareholder, majority owned subsidiary or
affiliated (as defined in the Securities Act) corporate entity or (ii) acquires at least 250,000 shares of Registrable Securities (as adjusted for stock splits and combinations). 
  
 2.7 Amendment Of Registration Rights. Any provision of this Section 2 may be amended and the observance
thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Holders of a majority in interest of the Registrable Securities. Any amendment or
waiver effected in accordance with this Section 2.7 shall be binding upon each Holder and the Company. By acceptance of any benefits under this Section 2, the Holders hereby agree to be bound by the provisions hereunder. 
  
 2.8 Rule 144 Reporting. With a view to making available to the Holders
the benefits of certain rules and regulations of the SEC which may permit the sale of the Registrable Securities to the public without registration, so long as the Company is otherwise subject to the reporting requirements of the Exchange Act, the
Company agrees to use its reasonable best efforts to: 
  
 (a)
make and keep public information available, as those terms are understood and defined in Rule 144; 
  
 (b) file with the SEC, in a timely manner, all reports and other documents required of the Company under the Exchange Act; and 
  
 (c) so long as such Holder owns any Registrable Securities, furnish
to such Holder upon request: (i) a written statement by the Company as to its compliance with the reporting requirements of said Rule 144, and of the Exchange Act; (ii) a copy of the most recent annual or quarterly report of the Company; and (iii)
such other reports and documents as a Holder may reasonably request in availing itself of any rule or regulation of the SEC allowing it to sell any such securities without registration. 
  
 3. MISCELLANEOUS. 
  
 3.1 Entire Agreement. This Agreement, the Settlement Agreement, the documents referred to herein and therein and all Schedules and Exhibits hereto
and thereto constitute the entire agreement among the parties and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as specifically set forth herein or therein. 
  

 7 

 3.2 Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof
shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto and shall inure to the benefit of and be enforceable by each person who shall be a holder of the Securities from
time to time. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement. 
  
 3.3 Governing Law. This Agreement is to be construed in accordance with and governed by the internal laws of the State of California (as permitted by Section 1646.5 of the California Civil Code or any similar successor provision),
without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties. Any action or proceeding seeking to
enforce any provision of, or based on any right arising out of, this Agreement may be brought against any of the Parties only in the courts of the State of California, County of Santa Clara, or the federal district court serving such county. Each of
the Parties consents to the exclusive jurisdiction of such courts (and the appropriate appellate courts) in any such action or proceeding and waives any objection to venue laid therein. Process in any action or proceeding referred to in the
preceding sentence may be served on any party anywhere in the world. 
  
 3.4 Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such
provision were so excluded and shall be enforceable in accordance with its terms. 
  
 3.5 Amendment and Waiver. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively
or prospectively), only with the written consent of the Company and the Holders holding a majority in interest of the Registrable Shares. No such amendment shall be effective to the extent any such amendment affects any rights specifically granted
to a particular Holder and not to the other Holders. 
  
 3.6
Delays Or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party to this Agreement, upon any breach, default or noncompliance of another party shall impair any such right, power, or remedy, nor shall
it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of any similar breach, default or noncompliance thereafter occurring. Any waiver, permit, consent, or approval of any kind or character on
any party’s part of any breach, default or noncompliance under the Agreement or any waiver on such party’s part of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically set
forth in such writing. All remedies, either under this Agreement, by law, or otherwise afforded to the parties, shall be cumulative and not alternative. 
  
 3.7 Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (i) upon personal delivery to
the party to be notified; (ii) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day; (iii) five (5) days after having been sent by 

  

 8 

 
registered or certified mail, return receipt requested, postage prepaid; or (iv) one (1) day after deposit with a nationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at the address as set forth on the signature page hereof, and to Investor at the address set forth on the signature page hereof or at
such other address as the Company or Investor may designate, with a copy to Investors’ counsel, Skadden, Arps, Slate, Meagher & Flom LLP, 525 University Avenue, Suite 1100, Palo Alto, California 94301, Attention: Gregory C. Smith.

  
 3.8 Attorneys’ Fees. If any action at law or in
equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs, and disbursements in addition to any other relief to which such party may be entitled.

  
 3.9 Titles and Subtitles. The titles of the sections
and subsections of the Agreement are for convenience of reference only and are not to be considered in construing this Agreement. 
  
 3.10 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together
shall constitute one instrument. 
  
 [REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK] 
  

 9 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

  

			
	COMPANY
	
	 CREDENCE SYSTEMS CORPORATION

		
	 By
	 	 /s/    BYRON W. MILSTEAD

	 Name:
	 	 Byron W. Milstead

	 Title:
	 	 Vice President and General Counsel

		
	 Address:
	 	 
	 1421 California Circle

	 Milpitas, California 95035

  
 [SIGNATURE PAGE
TO REGISTRATION RIGHTS AGREEMENT] 

			
	INVESTORS
	
	 SCHLUMBERGER TECHNOLOGIES, INC.

		
	 By
	 	 /s/    TAIK-HAW LIM

	 Name:
	 	 Taik-Haw Lim

	 Title:
	 	 President

		
	 Address:
	 	 
	  

	  

	
	 SCHLUMBERGER B.V.

		
	 By
	 	 /s/    A. R. VERBERG

	 Name:
	 	 A. R. Verberg

	 Title:
	 	 Director

		
	 Address:
	 	 
	  

	  

  
 [SIGNATURE PAGE
TO REGISTRATION RIGHTS AGREEMENT]Employment Agreement between DrugMax, Inc. and Edgardo Mercadante

 Exhibit 10.1 
  
 EMPLOYMENT AGREEMENT 
  

This Employment Agreement (the “Agreement”) is made and entered into effective as of the first day of December, 2004, by and between DRUGMAX,
INC., a Nevada corporation (the “Company”), and EDGARDO MERCADANTE, an individual (“Executive”). 
  
 W I T N E S S E T H: 
  
 WHEREAS, the Company provides a wide variety of prescription and non-prescription healthcare-related diagnostic products used for the treatment of chronic
diseases through its specialty pharmacies and online, and distributes pharmaceuticals, overt-the-counter products, health and beauty aids, nutritional supplements and other related products through its wholesale distribution centers (such
activities, together with all other activities of the Company and its subsidiaries, as conducted at or prior to the termination of this Agreement, and any future activities reasonably related thereto which are contemplated by the Company and/or its
subsidiaries at the termination of this Agreement identified in writing by the Company to Executive at the date of such termination, are hereinafter referred to as the “Business Activities”); 
  
 WHEREAS, the Company desires to employ Executive upon the terms and subject
to the terms and conditions set forth in this Agreement; and, 
  
 WHEREAS, Executive desires to be employed by the Company upon the terms and subject to the conditions set forth in this Agreement. 
  
 NOW, THEREFORE, in consideration of the premises, the mutual promises, covenants and conditions herein contained and for other good and valuable
considerations, the receipt and sufficiency of which are hereby acknowledged, the parties hereto intending to be legally bound hereby agree as follows: 
  
 Section 1. Employment. The Company hereby employs Executive, and Executive hereby accepts employment with the Company, all upon the terms and
subject to the conditions set forth in this Agreement. 
  
 Section
2. Capacity and Duties. Executive is and shall be employed in the capacity of Chief Executive Officer and Co-Chairman of the Board of Directors of the Company and shall have such duties, responsibilities and authorities as are assigned to him
by the Board of Directors of the Company (the “Board”). Subject to the control and general directions of, and the general policies and guidelines established, by the Board and except as otherwise herein provided, Executive shall devote
such of his business time, best efforts and attention as necessary to promote and advance the business of the Company and its subsidiaries and to perform diligently and faithfully all the duties, responsibilities and obligations of Executive to be
performed by him under this Agreement. Executive’s duties shall include ongoing management and oversight of the general business operations of the Company and its subsidiaries. During the Employment Period (as hereinafter defined), Executive
may engage in other business activities; provided, however, that such activities do not unreasonably interfere with Executive’s performance of his obligations hereunder or violate Section 15 or Section 18 hereof; and provided,
further, that any such activity is fully disclosed to the Company. 
  
 Section 3. Term of Employment. The initial term of employment of Executive by the Company pursuant to this Agreement shall be for the period (the “Initial Term”) commencing on December 1, 2004 (the
“Commencement Date”) and ending on November 30, 2005, or such earlier date that Executive’s employment is terminated in accordance with the provisions of this Agreement. The Initial Term automatically shall be extended for successive
additional one year periods (each, an “Extended Term”) unless written notice is given by either party to the other party no later than 30 days prior to the expiration of the Initial Term or any Extended Term. (The Initial Term, together
with each and any Extended Term, is sometimes hereinafter called the “Employment Period”). 
  
 Section 4. Place of Employment. Executive’s principal place of work shall be located at the principal offices of the Company in Farmington,
Connecticut. 

 Section 5. Compensation. During the Employment Period, subject to all the terms and conditions of
this Agreement and as compensation for all services to be rendered by Executive under this Agreement, the Company shall pay to or provide Executive with the following: 
  
 5.01 Base Salary. The Company shall compensate Executive during the Initial Term for his services
hereunder with a base annual salary of Three Hundred Forty-Six Thousand Four Hundred and Sixty-Six and 12/100 Dollars ($346,466.12), payable at such intervals (at least biweekly), net of applicable federal state and local taxes of any kind required
by law to be withheld with respect to such payment, as salaries are paid generally to other executive officers of the Company. Executive’s salary may be adjusted on an annual basis for the first and each successive Extended Term. The Company
shall give notice to Executive of any such adjustment no later than 45 days prior to the expiration of the Initial Term or any Extended Term. 
  
 5.02 Cash Bonus. The Company may pay to Executive a cash or other bonus on an annual or other basis in the sole discretion of the
Compensation Committee of the Board and Executive shall become a participant in any incentive compensation or bonus plan adopted by the Board for any highly compensated officers or other significant employees of the Company on such terms as shall be
determined by the Compensation Committee of the Board. Any amounts paid or payable to or on behalf of Employee shall be prorated through the Date of Termination. 
  
 5.03 Other Benefits. The Company shall provide Executive with the other benefits specified on Exhibit
5.03 attached hereto. 
  
 Section 6. Adherence to
Standards. Executive shall comply with the written policies, standards, rules and regulations of the Company from time to time established for all executive officers of the Company. 
  
 Section 7. Review of Performance. The Board and/or the Chief Executive Officer of the Company shall periodically
review and evaluate the performance of Executive under this Agreement with Executive. 
  
 Section 8. Expenses. The Company shall reimburse Executive for all reasonable, ordinary and necessary expenses (including, but not limited to, automobile and other business travel and customer entertainment
expenses) incurred by him in connection with his employment hereunder in accordance with Company policy; provided, however, Executive shall render to the Company a complete and accurate accounting of all such expenses in accordance with the
substantiation requirements of Section 274 of the Internal Revenue Code of 1986, as amended (the “Code”), as a condition precedent to such reimbursement. 
  
 Section 9. Termination with Cause by the Company. This Agreement may be terminated with Cause (as hereinafter
defined) by the Company provided that the Company shall (i) give Executive the Notice of Termination (as hereinafter defined), and (ii) pay Executive his annual base salary through the Termination Date (as hereinafter defined) at the rate in effect
at the time the Notice of Termination is given, plus any bonus or incentive compensation which has been earned or has become payable pursuant to the terms of any compensation or benefit plan as of the Termination Date, but which has not yet been
paid. Notwithstanding the foregoing, if Executive is terminated with Cause pursuant to Section 11.02(ii) and, subsequently, charges are dropped, Executive is found not guilty or otherwise cleared of wrongdoing, before or after trial or following
appeal, then in such event, the Company shall promptly thereupon recommence payments to Executive (or to his estate in the event of Executive’s death) in the amount of the compensation and other benefits described in Section 5 of this Agreement
for a period of 24 months, increased by such amount as may be necessary to make Executive whole for any incremental taxes due as a result of such continuance of payments. 
  
 Section 10. Termination without Cause by the Company or for Good Reason by Executive; Non-Renewal. This Agreement may
be terminated by (i) the Company by reason of the death or Disability (as hereinafter defined) of Executive or for no reason at all, or (ii) Executive for Good Reason (as hereinafter defined); provided that if this Agreement is terminated pursuant
to either of subsections (i) or (ii) of this Section 10 prior to November 30, 2007, or if the Company fails to renew this Agreement (as permitted by Section 3) through November 30, 2007, the Company shall continue to pay to Executive (or to his
estate in the event of termination due to Executive’s 

 death) the compensation and other benefits described in Section 5 of this Agreement until November 30, 2007, increased by
such amount as may be necessary to make Executive whole for any incremental taxes due because such payments are deemed to be an excess parachute payment, as such term is defined in Section 280G(b)(2) of the Internal Revenue Code of 1986, as amended
(whether such payments are paid in cash or stock, as permitted pursuant to this Section 10). If the Executive should fail to renew this Agreement at any time or if the Company should fail to renew the Agreement after November 30, 2007, the Company
shall not be required to pay any compensation to Executive other than his annual base salary through the last day of the then current term of the Employment Period, plus any bonus or incentive compensation which has been earned or has become payable
pursuant to the terms of any compensation or benefit plan as of such date but which has not yet been paid. 
  
 Executive’s right to terminate his employment for Good Reason shall not be affected by his incapacity due to physical or mental illness. In the event
of termination by reason of Executive’s death or Disability, medical, hospitalization or disability benefits coverage comparable to those provided by the Company during Executive’s lifetime shall be provided to his spouse and dependents
for the remaining term of this Agreement. The benefits provided under this Section 10 shall not be less favorable to Executive in terms of amounts, deductibles and costs to him, if any, than such benefits provided by the Company to him and his
dependents as of the Termination Date. This Section 10 shall not be interpreted so as to limit any benefits to which Executive, as a terminated employee of the Company, or his family may be entitled under the Company’s life insurance, medical,
hospitalization or disability plans following his Termination Date or under applicable law. 
  
 Any sums payable to Executive pursuant to this Section 10 may be paid to Executive either in cash or shares of common stock of the Company, in the Executive’s sole discretion. Any portion of such sums that are
paid in cash shall be paid to Executive at such intervals (at least biweekly), net of applicable federal state and local taxes of any kind required by law to be withheld with respect to such payment, as salaries are paid generally to other executive
officers of the Company. Upon the breach by Executive of Section 18 of this Agreement, the Company shall be entitled to cease making any such cash payments to Executive. 
  
 If Executive elects to receive any portion of such sum in common stock, the number of shares due to Executive shall be
determined by dividing such sum by the average closing price per share of the common stock during the ten trading days immediately preceding the termination or expiration, as applicable, of this Agreement. One-third of such shares shall be paid
within thirty days of termination or non-renewal, as applicable, and two-thirds of such shares shall be paid on the last day of the non-competition period contemplated by Section 18 of this Agreement; provided, however, that if the non-competition
period extends for more than one year after such termination or expiration, as applicable, one-third of such shares shall be paid within thirty days of termination or non-renewal, as applicable, one-third of the shares shall be paid on the first
anniversary of such termination or expiration, as applicable, and the remaining shares shall be paid on the last day of the non-competition period contemplated by Section 18 of this Agreement; provided, further, that should Executive breach Section
18 of this Agreement, any shares that have not yet been paid shall be canceled and returned to the Company. Upon receipt of each tranche of shares of common stock pursuant hereto by Executive, such shares shall constitute “Registrable
Securities” pursuant to the Registration Rights and Lock Up Agreement between Executive and the Company dated November 12, 2004, and as promptly as commercially reasonable thereafter, but in any event within 60 days, pursuant to the terms and
conditions of such Registration Rights and Lock Up Agreement, the Company shall register the resale of such shares and keep the registration statement in effect for not less than three (3) years. 
  
 Section 11. Definitions. In addition to the words and terms elsewhere
defined in this Agreement, certain capitalized words and terms used in this Agreement shall have the meanings given to them by the definitions and descriptions in this Section 11 unless the context or use indicates another or different meaning or
intent, and such definition shall be equally applicable to both the singular and plural forms of any of the capitalized words and terms herein defined. The following words and terms are defined terms under this Agreement: 
  
 11.01 “Disability” shall mean a physical or mental
illness which, in the judgment of the Company after consultation with the licensed physician attending Executive, impairs Executive’s ability to substantially perform his duties under this Agreement as an employee and as a result of which he
shall have been absent from his duties with the Company on a full-time basis for six consecutive months. 

 11.02 A termination with “Cause” shall mean a termination of this Agreement by
reason of (i) Executive’s conviction of a felony or a crime involving moral turpitude or any other crime involving dishonesty, disloyalty or fraud with respect to the Company; (ii) Executive’s arrest or indictment of any lesser crime or
offense committed in connection with the performance of Executive’s duties hereunder; or (iii) a good faith determination by the Board that Executive (a) failed or refused to substantially perform his duties with the Company (other than a
failure resulting from his incapacity due to physical or mental illness) after a written demand for substantial performance has been delivered to him by the Board, which demand specifically identifies the manner in which the Board believes he has
not substantially performed his duties and provides a reasonable cure period, and Executive continues to refuse or fail to substantially perform as directed by the Board through the duration of the cure period; or (b) Executive’s breach of any
of the covenants set forth in Sections 15, 16 or 18 hereof. No act, or failure to act, on Executive’s part shall be grounds for termination with Cause unless he has acted or failed to act with an absence of good faith or without a reasonable
belief that his action or failure to act was in or at least not opposed to the best interests of the Company. Notwithstanding the foregoing, Executive shall not be deemed to have been terminated with Cause unless there shall have been delivered to
him a copy of a resolution duly adopted by the affirmative vote of not less than a majority of the entire membership of the Board (exclusive of Executive) at a meeting of the Board called and held for the purpose of terminating Executive (after
reasonable notice to Executive and opportunity for him, together with his counsel, to be heard before the Board), finding that in the good faith opinion of the Board, Executive failed to perform his duties or engaged in conduct in the manner or of
the type set forth above in the first sentence of this Section 11.02 and specifying the particulars thereof in detail. 
  
 11.03 “Good Reason” shall mean the occurrence of any of the following events without Executive’s prior express written consent: (i) any
material change in his status, title, authorities or responsibilities (including reporting responsibilities) under this Agreement which represents a demotion from such status, title, position or responsibilities (including reporting
responsibilities); the assignment to him of any duties or work responsibilities which are materially inconsistent with his status, title, position or work responsibilities set forth in this Agreement or which are materially inconsistent with the
status, title, position or work responsibilities of a chief executive officer and co-chairman of the board of directors of a publicly-traded corporation; or any removal of Executive from, or failure to appoint, elect, reappoint or reelect Executive
to, any of such positions, except in connection with the termination of his employment with Cause, or as a result of his death or Disability; provided, however, that no change in title, authorities or responsibilities customarily
attributable solely to the Company ceasing to be a publicly traded corporation shall constitute Good Reason hereunder; (ii) the relocation of the principal office of the Company or the reassignment of Executive to a location more than thirty (30)
miles from Farmington, Connecticut; (iii) the failure by the Company to continue in effect any incentive, bonus or other compensation plan in which Executive participates, unless an equitable arrangement (embodied in an ongoing substitute or
alternative plan) has been made with respect to the failure to continue such plan, or the failure by the Company to continue Executive’s participation therein, or any action by the Company which would directly or indirectly materially reduce
his participation therein or reward opportunities thereunder; provided, however, that Executive continues to meet all eligibility requirements thereof; (iv) the failure by the Company to continue in effect any Executive benefit plan (including any
medical, hospitalization, life insurance or disability benefit plan in which Executive participates), or any material fringe benefit or prerequisite enjoyed by him unless an equitable arrangement (embodied in an ongoing substitute or alternative
plan) has been made with respect to the failure to continue such plan, or the failure by the Company to continue Executive’s participation therein, or any action by the Company which would indirectly or indirectly materially reduce his
participation therein or reward opportunities thereunder, or the failure by the Company to provide him with the benefits to which he is entitled under this Agreement; provided, however, that Executive continues to meet all eligibility requirements
thereof; (v) any other material breach by the Company of any provision of this Agreement; (vi) the failure of the Company to obtain a satisfactory agreement from any successor or assign of the Company to assume and agree to perform this Agreement,
as contemplated in Section 21 hereof; or (vii) any purported termination of Executive’s employment which is not effected pursuant to a Notice of Termination satisfying the requirements of this Agreement; and for purposes of this Agreement, no
such purported termination shall be effective. 
  
 11.04 Notice of Termination. “Notice of Termination” shall mean a written notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail 

 the facts and circumstances claimed to provide a basis for termination of Executive’s employment
under the provision so indicated; provided, however, no such purported termination shall be effective without such Notice of Termination; provided further, however, any purported termination by the Company or by Executive shall be communicated by a
Notice of Termination to the other party hereto in accordance with Section 4 of this Agreement. 
  
 11.05 Termination Date. “Termination Date” shall mean the date specified in the Notice of Termination (which, in the case
of a termination pursuant to Section 9 of this Agreement shall not be less than 60 days, and in the case of a termination pursuant to Section 10 of this Agreement shall not be more than 60 days, from the date such Notice of Termination is given);
provided, however, that if within 30 days after any Notice of Termination is given the party receiving such Notice of Termination notifies the other party that a dispute exists concerning the termination, the Termination Date shall be the date
finally determined by either mutual written agreement of the parties or by the final judgment, order or decree of a court of competent jurisdiction (the time for appeal therefrom having expired and no appeal having been taken). 
  
 Section 12. Fees and Expenses. The Company shall pay all legal fees
and related expenses (including the costs of experts, evidence and counsel) incurred by Executive as a result of a contest or dispute over Executive’s termination of employment if such contest or dispute is resolved in Executive’s favor.

  
 Section 13. Notices. For the purposes of this
Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or sent by certified mail, return receipt requested, postage prepaid, or by
expedited (overnight) courier with established national reputation, shipping prepaid or billed to sender, in either case addressed to the respective addresses last given by each party to the other (provided that all notices to the Company shall be
directed to the attention of the Board with a copy to the Secretary of the Company) or to such other address as either party may have furnished to the other in writing in accordance herewith. All notices and communication shall be deemed to have
been received on the date of delivery thereof, on the third business day after the mailing thereof, or on the second day after deposit thereof with an expedited courier service, except that notice of change of address shall be effective only upon
receipt. 
  
 Section 14. Life Insurance. The Company may,
at any time after the execution of this Agreement, apply for and procure as owner and for its own benefit, life insurance on Executive, in such amounts and in such form or forms as the Company may determine. Executive shall, at the request of the
Company, submit to such medical examinations, supply such information, and execute such documents as may be required by the insurance company or companies to whom the Company has applied for such insurance. Executive hereby represents that to his
knowledge he is in excellent physical and mental condition and is not under the influence of alcohol, drugs or similar substance. 
  
 Section 15. Proprietary Information and Inventions. Executive understands and acknowledges that: 
  
 15.01 Trust. Executive’s employment creates a
relationship of confidence and trust between Executive and the Company with respect to certain information applicable to the business of the Company and its subsidiaries (collectively, the “Group”) or applicable to the business of any
vendor or customer of any of the Group, which may be made known to Executive by the Group or by any vendor or customer of any of the Group or learned by Executive during the Employment Period. 
  
 15.02 Proprietary Information. The Group possesses
and will continue to possess information that has been created, discovered, or developed by, or otherwise become known to, the Group (including, without limitation, information created, discovered, developed or made known to by Executive during the
period of or arising out of my employment by the Company) or in which property rights have been or may be assigned or otherwise conveyed to the Group, which information has commercial value in the business in which the Group is engaged and is
treated by the Group as confidential. Except as otherwise herein provided, all such information is hereinafter called “Proprietary Information,” which term, as used herein, shall also include, but shall not be limited to, data, functional
specifications, computer programs, know-how, research, technology, improvements, developments, designs, marketing plans, strategies, forecasts, new products, unpublished financial statements, budgets, projections, licenses, franchises, prices,
costs, and customer, supplier and potential acquisition candidates lists. Notwithstanding anything contained in this Agreement to the contrary, the 

 term “Proprietary Information” shall not include (i) information which is in the public domain,
(ii) information which is published or otherwise becomes part of the public domain through no fault of Executive, (iii) information which Executive can demonstrate was in Executive’s possession at the time of disclosure and was not acquired by
Executive directly or indirectly from any of the Group on a confidential basis, (iv) information which becomes available to Executive on a non-confidential basis from a source other than any of the Group and which source, to the best of
Executive’s knowledge, did not acquire the information on a confidential basis, or (v) information required to be disclosed by any federal or state law, rule or regulation or by any applicable judgment, order or decree or any court or
governmental body or agency having jurisdiction in the premises. 
  
 All
Proprietary Information shall be the sole property of the Group and their respective assigns. Executive assigns to the Company any rights Executive may have or acquire in such Proprietary Information. At all times, both during Executive’s
employment by the Company and after its termination, Executive shall keep in strictest confidence and trust all Proprietary Information, and Executive shall not use or disclose any Proprietary Information without the written consent of the Group,
except as may be necessary in the ordinary course of performing Executive’s duties as an Executive of the Company. 
  
 Section 16. Surrender of Documents; No Disparagement. Executive shall, at the request of the Company, promptly surrender to the Company or its
nominee any Proprietary Information or document, memorandum, record, letter or other paper in his possession or under his control relating to the operation, business or affairs of the Group. Executive further agrees that he shall not, either during
the Employment Period or at any time thereafter, in any way disparage the Company. 
  
 Section 17. Other Agreements. Executive represents and warrants that Executive’s performance of all the terms of this Agreement and as an Executive of the Company does not, and will not, breach any
agreement to keep in confidence proprietary information acquired by Executive in confidence or in trust prior to Executive’s employment by the Company. Executive has not entered into, and shall not enter into, any agreement, either written or
oral, which is in conflict with this Agreement or which would be violated by Executive entering into, or carrying out his obligations under, this Agreement. 
  
 Section 18. Restrictive Covenant. Executive acknowledges and recognizes Executive’s possession of Proprietary Information and the highly
competitive nature of the business of the Group and, accordingly, agrees that in consideration of the premises contained herein Executive will not, during the period of Executive’s employment by the Company and for the period ending on the
later of November 30, 2007, or the first anniversary of the Termination Date, (i) directly or indirectly engage in any Business Activities in the United States, whether such engagement shall be as an employer, officer, director, owner, employee,
consultant, stockholder, partner or other participant in any Business Activities, (ii) assist others in engaging in any Business Activities in the manner described in the foregoing clause (i), or (iii) induce employees of the Company to terminate
their employment with the Company or engage in any Business Activities in the United States; provided, however, that the ownership of no more than two percent of the outstanding capital stock of a corporation whose shares are traded on a national
securities exchange or on the over-the-counter market shall not be deemed engaging in any Business Activities. Notwithstanding the foregoing, if the Company fails to make any payment required by Section 10 of this Agreement within five days of
notice of non-payment by Executive to the Company, then the covenants in this Section 18 immediately shall terminate. 
  
 Section 19. Remedies. Executive acknowledges and agrees that the Company’s remedy at law for a breach or a threatened breach of the provisions
herein would be inadequate, and in recognition of this fact, in the event of a breach or threatened breach by Executive of any of Sections 15, 16, 17 or 18 of this Agreement, it is agreed that the Company shall be entitled to equitable relief in the
form of specific performance, a temporary restraining order, a temporary or permanent injunction or any other equitable remedy which may then be available, without posting bond or other security. Executive acknowledges that the granting of a
temporary injunction, a temporary restraining order or other permanent injunction merely prohibiting Executive from engaging in any Business Activities would not be an adequate remedy upon breach or threatened breach of this Agreement, and
consequently agrees upon any such breach or threatened breach to the granting of injunctive relief prohibiting Executive from engaging in any activities prohibited by this Agreement. No remedy herein conferred is intended to be exclusive of any
other remedy, and each and every such remedy shall be cumulative and shall be in addition to any other remedy given hereunder now or hereinafter existing at law or in equity or by statute or otherwise. 

 Section 20. Successive Employment Notice. Within five business days after the Termination Date,
Executive shall provide notice to the Company of Executive’s next intended employment. If such employment is not known by Executive at such date, Executive shall notify the Company immediately upon determination of such information. Executive
shall continue to provide the Company with notice of Executive’s place and nature of employment and any change in place or nature of employment during the period ending two years after the Termination Date. Failure of Executive to provide the
Company with such information in an accurate and timely fashion shall be deemed to be a breach of this Agreement and shall entitle the Company to all remedies provided for in this Agreement as a result of such breach. 
  
 Section 21. Successors. This Agreement shall be binding on the Company
and any successor to any of its businesses or assets. Without limiting the effect of the prior sentence, the Company shall use its best efforts to require any successor or assign (whether direct or indirect, by purchase, merger, consolidation or
otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such
succession or assignment had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor or assign to its business and/or assets as aforesaid which assumes and agrees to perform this
Agreement or which is otherwise obligated under this Agreement by the first sentence of this Section 21, by operation of law or otherwise. 
  
 Section 22. Binding Effect. This Agreement shall inure to the benefit of and be enforceable by Executive’s personal and legal representatives,
executors, administrators, successors, heirs, distributees, devisees and legatees. If Executive should die while any amounts would still be payable to him hereunder if he had continued to live, all such amounts, unless otherwise provided herein,
shall be paid in accordance with the terms of this Agreement to Executive’s estate. 
  
 Section 23. Modification and Waiver. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing and signed by Executive and such
officer as may be specifically designated by the Board. No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party
shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. 
  
 Section 24. Headings. Headings used in this Agreement are for convenience only and shall not be used to interpret or construe its provisions.

  
 Section 25. Amendments. No amendments or variations of
the terms and conditions of this Agreement shall be valid unless the same is in writing and signed by each of the parties hereto. 
  
 Section 26. Severability. The invalidity or unenforceability of any provision of this Agreement, whether in whole or in part, shall not in any way
affect the validity or enforceability of any other provision herein contained. Any invalid or unenforceable provision shall be deemed severable to the extent of any such invalidity or unenforceability. It is expressly understood and agreed that,
while the Company and Executive consider the restrictions contained in this Agreement reasonable for the purpose of preserving for the Company the goodwill, other proprietary rights and intangible business value of the Company, if a final judicial
determination is made by a court having jurisdiction that the time or territory or any other restriction contained in this Agreement is an unreasonable or otherwise unenforceable restriction against Executive, the provisions of such clause shall not
be rendered void but shall be deemed amended to apply as to maximum time and territory and to such other extent as such court may judicially determine or indicate to be reasonable. 
  
 Section 27. Governing Law; Venue. This Agreement shall be construed and enforced pursuant to the laws of the State of
Connecticut, excluding its choice of law provisions. Both parties submit to the jurisdiction of the United States District Court, District of Connecticut at Hartford, and the Circuit Court in and for Hartford County, 

 Connecticut, as the exclusive proper forum in which to adjudicate any case or controversy arising hereunder. The
prevailing party shall be entitled to an award of its reasonable attorneys’ fees incurred in connection with any such judicial proceedings. 
  
 Section 28. Counterparts. This Agreement may be executed in more than one counterpart and each counterpart shall be considered an original.

  
 Section 29. Exhibits. The Exhibits attached hereto are
incorporated herein by reference and are an integral part of this Agreement. 
  
 IN WITNESS WHEREOF, this Agreement has been duly executed by the Company and Executive in four counterparts as of the date first above written. 
  

			
	DRUGMAX, INC.
		
	By:	 	 /s/ Peter Grua

	 	 	Peter Grua, Chairman, Compensation Committee
	
	EXECUTIVE
	
	 /s/ Edgardo Mercadante

	EDGARDO MERCADANTE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]